Literature DB >> 26322168

Multifunctional facets of retrovirus integrase.

Duane P Grandgenett1, Krishan K Pandey1, Sibes Bera1, Hideki Aihara1.   

Abstract

The retrovirus integrase (IN) is responsible for integration of the reverse transcribed linear cDNA into the host DNA genome. First, IN cleaves a dinucleotide from the 3' OH blunt ends of the viral DNA exposing the highly conserved CA sequence in the recessed ends. IN utilizes the 3' OH ends to catalyze the concerted integration of the two ends into opposite strands of the cellular DNA producing 4 to 6 bp staggered insertions, depending on the retrovirus species. The staggered ends are repaired by host cell machinery that results in a permanent copy of the viral DNA in the cellular genome. Besides integration, IN performs other functions in the replication cycle of several studied retroviruses. The proper organization of IN within the viral internal core is essential for the correct maturation of the virus. IN plays a major role in reverse transcription by interacting directly with the reverse transcriptase and by binding to the viral capsid protein and a cellular protein. Recruitment of several other host proteins into the viral particle are also promoted by IN. IN assists with the nuclear transport of the preintegration complex across the nuclear membrane. With several retroviruses, IN specifically interacts with different host protein factors that guide the preintegration complex to preferentially integrate the viral genome into specific regions of the host chromosomal target. Human gene therapy using retrovirus vectors is directly affected by the interactions of IN with these host factors. Inhibitors directed against the human immunodeficiency virus (HIV) IN bind within the active site of IN containing viral DNA ends thus preventing integration and subsequent HIV/AIDS.

Entities:  

Keywords:  Atomic structure; Host factors; Human immunodeficiency virus integrase inhibitors; Integration; Retrovirus integrase

Year:  2015        PMID: 26322168      PMCID: PMC4549773          DOI: 10.4331/wjbc.v6.i3.83

Source DB:  PubMed          Journal:  World J Biol Chem        ISSN: 1949-8454


  95 in total

Review 1.  Structural insights into the retroviral DNA integration apparatus.

Authors:  Peter Cherepanov; Goedele N Maertens; Stephen Hare
Journal:  Curr Opin Struct Biol       Date:  2011-02-01       Impact factor: 6.809

2.  Nuclear architecture dictates HIV-1 integration site selection.

Authors:  Bruna Marini; Attila Kertesz-Farkas; Hashim Ali; Bojana Lucic; Kamil Lisek; Lara Manganaro; Sandor Pongor; Roberto Luzzati; Alessandra Recchia; Fulvio Mavilio; Mauro Giacca; Marina Lusic
Journal:  Nature       Date:  2015-03-02       Impact factor: 49.962

3.  Physical trapping of HIV-1 synaptic complex by different structural classes of integrase strand transfer inhibitors.

Authors:  Krishan K Pandey; Sibes Bera; Ajaykumar C Vora; Duane P Grandgenett
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

Review 4.  Interfacial inhibitors: targeting macromolecular complexes.

Authors:  Yves Pommier; Christophe Marchand
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

Review 5.  HIV-1 integrase multimerization as a therapeutic target.

Authors:  Lei Feng; Ross C Larue; Alison Slaughter; Jacques J Kessl; Mamuka Kvaratskhelia
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

6.  Avian retrovirus pp32 DNA binding protein. Preferential binding to the promoter region of long terminal repeat DNA.

Authors:  R J Knaus; P J Hippenmeyer; T K Misra; D P Grandgenett; U R Müller; W M Fitch
Journal:  Biochemistry       Date:  1984-01-17       Impact factor: 3.162

7.  The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites.

Authors:  Jan De Rijck; Christine de Kogel; Jonas Demeulemeester; Sofie Vets; Sara El Ashkar; Nirav Malani; Frederic D Bushman; Bart Landuyt; Steven J Husson; Katrien Busschots; Rik Gijsbers; Zeger Debyser
Journal:  Cell Rep       Date:  2013-10-31       Impact factor: 9.423

8.  A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration.

Authors:  L A Donehower; H E Varmus
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells.

Authors:  Arianna Moiani; Julia Debora Suerth; Francesco Gandolfi; Ermanno Rizzi; Marco Severgnini; Gianluca De Bellis; Axel Schambach; Fulvio Mavilio
Journal:  Genes (Basel)       Date:  2014-05-16       Impact factor: 4.096

View more
  6 in total

1.  The Preserved HTH-Docking Cleft of HIV-1 Integrase Is Functionally Critical.

Authors:  Meytal Galilee; Elena Britan-Rosich; Sarah L Griner; Serdar Uysal; Viola Baumgärtel; Don C Lamb; Anthony A Kossiakoff; Moshe Kotler; Robert M Stroud; Ailie Marx; Akram Alian
Journal:  Structure       Date:  2016-09-29       Impact factor: 5.006

2.  A C-terminal "Tail" Region in the Rous Sarcoma Virus Integrase Provides High Plasticity of Functional Integrase Oligomerization during Intasome Assembly.

Authors:  Krishan K Pandey; Sibes Bera; Ke Shi; Hideki Aihara; Duane P Grandgenett
Journal:  J Biol Chem       Date:  2017-02-08       Impact factor: 5.157

3.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

Review 4.  Retroviral integrase protein and intasome nucleoprotein complex structures.

Authors:  Julia Grawenhoff; Alan N Engelman
Journal:  World J Biol Chem       Date:  2017-02-26

5.  In vitro Susceptibility of Human Cell Lines Infection by Bovine Leukemia Virus.

Authors:  Nury N Olaya-Galán; Skyler Blume; Kan Tong; HuaMin Shen; Maria F Gutierrez; Gertrude C Buehring
Journal:  Front Microbiol       Date:  2022-03-14       Impact factor: 5.640

6.  Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells Through Inhibition of Human Endogenous Retrovirus Type K.

Authors:  Jiayi Li; John Lin; John R Lin; Mason Farris; Lauren Robbins; Leo Andrada; Bryce Grohol; Serrat Nong; Yingguang Liu
Journal:  Cureus       Date:  2022-07-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.